Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Shares Issued (2016 - 2025)

Ingevity (NGVT) has disclosed Shares Issued for 10 consecutive years, with $800000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued changed N/A to $800000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $800000.0, a N/A change, with the full-year FY2025 number at $1.4 million, changed N/A from a year prior.
  • Shares Issued was $800000.0 for Q4 2025 at Ingevity, up from $700000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $2.6 million in Q1 2023 to a low of $500000.0 in Q3 2021.
  • A 4-year average of $1.2 million and a median of $1.0 million in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: crashed 50.0% in 2022, then soared 225.0% in 2023.
  • Ingevity's Shares Issued stood at $1.0 million in 2021, then increased by 30.0% to $1.3 million in 2022, then plummeted by 46.15% to $700000.0 in 2023, then increased by 14.29% to $800000.0 in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Shares Issued are $800000.0 (Q4 2025), $700000.0 (Q3 2023), and $1.4 million (Q2 2023).